The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received…
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new…
The Food and Drug Administration on Wednesday announced what the agency calls a “historic action” — the first approval of a gene therapy in the…